Patients living with GERD now have a new treatment option for improved and
sustained symptom relief

DEXILANT is the First Proton Pump Inhibitor (PPI) with a DUAL DELAYED RELEASE (DDR) Technology

MISSISSAUGA, ON, Sept. 22 /CNW/ - To view this Social Media Release, please enter the following address in your web browser.

http://smr.newswire.ca/en/takeda-canada-inc/patients-living-with-gerd-now-have-a-new-treatment

For further information: For a complete listing of social media releases available through CNW Group, please visit our calendar at http://smr.newswire.ca